Sun Pharma’s Q2 Profit Surges 28% to Rs 3,040 Crore
Sun Pharmaceutical Industries reported a 28% year-on-year jump in net profit to Rs 3,040 crore for Q2 FY25, surpassing market expectations. The strong earnings were driven by favorable seasonality and robust sales in the specialty segment. Revenue from operations rose 9% to Rs 13,291 crore, closely aligning with analysts’ estimates. The company’s EBITDA margin expanded […]
Sun Pharma’s Q2 Profit Surges 28% to Rs 3,040 Crore Read More »